MicroRNAs as critical regulators involved in regulating epithelial-mesenchymal transition

Current Cancer Drug Targets

Volumn 13, Issue 9, 2013, Pages 935-944

  Zhao, Xiaodi ^a   Lu, Yuanyuan ^a   Nie, Yongzhan ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Embryogenesis; EMT; Fibrosis; MET; Metastasis; MicroRNA

Indexed keywords

ACTIVIN; ALPHA CATENIN; BONE MORPHOGENETIC PROTEIN; DNA DIRECTED RNA POLYMERASE III; EPIDERMAL GROWTH FACTOR; EXPORTIN 5; GROWTH DIFFERENTIATION FACTOR; INHIBIN; MICRORNA; MICRORNA 141; MICRORNA 200; MICRORNA 31; MICRORNA 34A; NERVE CELL ADHESION MOLECULE; PLATELET DERIVED GROWTH FACTOR; RNA POLYMERASE II; SCATTER FACTOR; SMAD PROTEIN; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UVOMORULIN; VIMENTIN;

BIOGENESIS; CANCER GROWTH; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; FIBROGENESIS; FIBROSIS; GENE CONTROL; GENE EXPRESSION; HUMAN; METASTASIS; NEOPLASM; NONHUMAN; REGULATORY MECHANISM; REVIEW; TISSUE REPAIR; TRANSLATION REGULATION; WOUND HEALING;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84890831249     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/15680096113136660099     Document Type: Review

References (99)

1. Yang, J.; Weinberg, R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 2008, 14(6), 818-829.
2. Kalluri, R.; Neilson, E. G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003, 112(12), 1776-1784.
3. Thiery, J. P.; Acloque, H.; Huang, R. Y; Nieto, M. A. Epithelialmesenchymal transitions in development and disease. Cell 2009, 139(5), 871-890.
4. Hay, E. D. An overview of epithelio-mesenchymal transformation. Acta Anat. (Basel) 1995, 154(1), 8-20.
5. Mani, S. A.; Guo, W.; Liao, M. J.; Eaton, E. N.; Ayyanan, A.; Zhou, A. Y.; Brooks, M.; Reinhard, F.; Zhang, C. C.; Shipitsin, M.; Campbell, L. L.; Polyak, K.; Brisken, C.; Yang, J.; Weinberg, R. A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133(4), 704-715.
6. Kalluri, R.; Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119(6), 1420-1428.
7. Cannito, S.; Novo, E.; di Bonzo, L. V.; Busletta, C.; Colombatto, S.; Parola, M. Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid. Redox Signal. 2010, 12(12), 1383-1430.
8. Moustakas, A.; Heldin, C. H. Signaling networks guiding epithelialmesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007, 98(10), 1512-1520.
9. Peinado, H.; Olmeda, D.; Cano, A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 2007, 7(6), 415-428.
10. Moreno-Bueno, G.; Portillo, F.; Cano, A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008, 27(55), 6958-6969.
11. Takeichi, M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 1995, 7(5), 619-627.
12. Iwatsuki, M.; Mimori, K.; Yokobori, T.; Ishi, H.; Beppu, T.; Nakamori, S.; Baba, H.; Mori, M. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010, 101(2), 293-299.
13. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2), 281-297.
14. Saini, H. K.; Griffiths-Jones, S.; Enright, A. J. Genomic analysis of human microRNA transcripts. Proc. Natl. Acad. Sci. USA 2007, 104(45), 17719-17724.
15. Rodriguez, A.; Griffiths-Jones, S.; Ashurst, J. L.; Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res., 2004, 14(10A), 1902-1910.
16. Lee, Y.; Jeon, K.; Lee, J. T.; Kim, S.; Kim, V. N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002, 21(17), 4663-4670.
17. Bohnsack, M. T.; Czaplinski, K.; Gorlich, D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004, 10(2), 185-191.
18. Gregory, R. I.; Chendrimada, T. P.; Cooch, N.; Shiekhattar, R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123(4), 631-640.
19. Davis, B. N.; Hata, A. Regulation of MicroRNA biogenesis: A miRiad of mechanisms. Cell Commun. Signal. 2009, 7, 18.
20. Szabo, G.; Bala, S. MicroRNAs in liver disease. Nat. Rev. Gastroenterol. Hepatol. 2013, 10(9), 542-552.
21. Kozomara, A.; Griffiths-Jones, S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39(Database issue), D152-D157.
22. Chaudhuri, K.; Chatterjee, R. MicroRNA detection and target prediction: integration of computational and experimental approaches. DNA Cell Biol. 2007, 26(5), 321-337.
23. Ventura, A.; Jacks, T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009, 136(4), 586-591.
24. Massague, J. TGFbeta in Cancer. Cell 2008, 134(2), 215-230.
25. Chang, H.; Brown, C. W.; Matzuk, M. M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev. 2002, 23(6), 787-823.
26. Zavadil, J.; Bottinger, E. P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24(37), 5764-5774.
27. Xu, J.; Lamouille, S.; Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009, 19(2), 156-172.
28. Zavadil, J.; Bottinger, E. P. TGF-beta and epithelial-tomesenchymal transitions. Oncogene 2005, 24(37), 5764-5774.
29. Braun, J.; Hoang-Vu, C.; Dralle, H.; Hüttelmaier, S. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 2010, 29(29), 4237-4244.
30. Zhong, H.; Wang, H. R.; Yang, S.; Zhong, J.H.; Wang, T.; Wang, C.; Chen, F.Y. Targeting Smad4 links microRNA-146a to the TGFbeta pathway during retinoid acid induction in acute promyelocytic leukemia cell line. Int. J. Hematol. 2010, 92(1), 129-135.
31. Rogler, C. E.; Levoci, L.; Ader, T. Massimi, A.; Tchaikovskaya, T.; Norel, R.; Rogler, L.E. MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 2009, 50(2), 575-584.
32. Shan, H.; Zhang, Y.; Lu, Y.; Zhang, Y.; Pan, Z.; Cai, B.; Wang, N.; Li, X.; Feng, T.; Hong, Y.; Yang, B. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc. Res., 2009, 83(3), 465-472.
33. Marquez, R. T.; Bandyopadhyay, S.; Wendlandt, E. B.; Keck, K.; Hoffer, B. A.; Icardi, M. S.; Christensen, R. N.; Schmidt, W. N.; McCaffrey, A. P. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest. 2010, 90(12), 1727-1736.
34. Liu, G.; Friggeri, A.; Yang, Y.; Milosevic, J.; Ding, Q.; Thannickal, V. J.; Kaminski, N.; Abraham, E. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 2010, 207(8), 1589-1597.
35. Wang, B.; Koh, P.; Winbanks, C.; Coughlan, M.T.; McClelland, A.; Watson, A.; Jandeleit-Dahm, K.; Burns, W. C.; Thomas, M. C.; Cooper, M. E.; Kantharidis, P. miR-200a Prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes 2011, 60(1), 280-287.
36. Qian, B.; Katsaros, D.; Lu, L.; Yu, H. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res. Treat. 2009, 117(1), 131-140.
37. Kim, Y. J.; Hwang, S. J.; Bae, Y. C.; Jung, J. S. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 2009, 27(12), 3093-3102.
38. Pan, Q.; Luo, X.; Chegini, N. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Mol. Hum. Reprod. 2010, 16(3), 215-227.
39. Mizuno, Y.; Tokuzawa, Y.; Ninomiya, Y.; Yagi, K.; Yatsuka-Kanesaki, Y.; Suda, T.; Fukuda, T.; Katagiri, T.; Kondoh, Y.; Amemiya, T.; Tashiro, H.; Okazaki, Y. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett. 2009, 583(13), 2263-2268.
40. Davis, B. N.; Hilyard, A. C.; Lagna, G.; Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454(7200), 56-61.
41. Davis, B. N.; Hilyard, A. C.; Nguyen, P. H.; Lagna, G.; Hata, A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol. Cell 2010, 39(3), 373-384.
42. Vandewalle, C.; Van Roy, F.; Berx, G. The role of the ZEB family of transcription factors in development and disease. Cell. Mol. Life. Sci. 2009, 66(5), 773-787.
43. Korpal, M.; Lee, E. S.; Hu, G.; Kang, Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283(22), 14910-14914.
44. Gregory, P. A.; Bert, A. G.; Paterson, E. L.; Barry, S. C, Tsykin, A.; Farshid, G.; Vadas, M. A.; Khew-Goodall, Y.; Goodall, G. J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10(5), 593-601.
45. Christoffersen, N. R.; Silahtaroglu, A.; Orom, U. A.; Kauppinen, S.; Lund, A. H. miR-200b mediates post-transcriptional repression of ZFHX1B. RNA 2007, 13(8), 1172-1178.
46. Hurteau, G. J.; Carlson, J. A.; Spivack, S. D.; Brock G. J. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of Ecadherin. Cancer Res. 2007, 67(17), 7972-7976.
47. Kurashige, J.; Kamohara, H.; Watanabe, M.; Hiyoshi, Y.; Iwatsuki, M.; Tanaka, Y.; Kinoshita, K.; Saito, S.; Baba, Y.; Baba, H. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann. Surg. Oncol. 2012, 19(Suppl. 3), S656-S664.
48. Shin, J. O.; Nakagawa, E.; Kim, E. J.; Cho, K. W.; Lee, J. M.; Cho, S. W.; Jung, H. S. miR-200b regulates cell migration via Zeb family during mouse palate development. Histochem. Cell Biol. 2012, 137(4), 459-470.
49. Stinson, S.; Lackner, M. R.; Adai, A. T.; Yu, N.; Kim, H. J.; O'Brien, C.; Spoerke, J.; Jhunjhunwala, S.; Boyd, Z.; Januario, T.; Newman, R. J.; Yue, P.; Bourgon, R.; Modrusan, Z.; Stern, H. M.; Warming, S.; de Sauvage, F. J.; Amler, L.; Yeh, R. F.; Dornan, D. TRPS1 targeting by miR-221/222 promotes the epithelial-tomesenchymal transition in breast cancer. Sci. Signal. 2011, 4(177), a41.
50. Bracken, C. P.; Gregory, P. A.; Kolesnikoff, N.; Bert, A. G.; Wang, J.; Shannon, M. F.; Goodall, G. J. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res., 2008, 68(19), 7846-7854.
51. Burk, U.; Schubert, J.; Wellner, U.; Schmalhofer, O.; Vincan, E.; Spaderna, S.; Brabletz, T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9(6), 582-589.
52. Brabletz, S.; Brabletz, T. The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer? EMBO Rep. 2010, 11(9), 670-677.
53. Bullock, M. D.; Sayan, A. E.; Packham, G. K.; Mirnezami, A. H. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol. Cell 2012, 104(1), 3-12.
54. Gregory, P. A.; Bracken, C. P.; Bert, A. G.; Goodall, G. J. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 2008, 7(20), 3112-3118.
55. Dykxhoorn, D. M.; Wu, Y.; Xie, H.; Yu, F.; Lal, A.; Petrocca, F.; Martinvalet, D.; Song, E.; Lim, B.; Lieberman, J. miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 2009, 4(9), e7181.
56. Korpal, M.; Ell, B. J.; Buffa, F. M.; Ibrahim, T.; Blanco, M. A.; Celià-Terrassa, T.; Mercatali, L.; Khan, Z.; Goodarzi, H.; Hua, Y.; Wei, Y.; Hu, G.; Garcia, B. A.; Ragoussis, J.; Amadori, D.; Harris, A. L.; Kang, Y. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med. 2011, 17(9), 1101-1108.
57. Lamouille, S.; Subramanyam, D.; Blelloch, R.; Derynck, R. Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr. Opin. Cell Biol. 2013, 25(2), 200-207.
58. Batlle, E.; Sancho, E.; Franci, C.; Domínguez, D.; Monfar, M.; Baulida, J.; García De Herreros, A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2000, 2(2), 84-89.
59. Kumarswamy, R.; Mudduluru, G.; Ceppi, P.; Muppala, S.; Kozlowski, M.; Niklinski, J.; Papotti, M.; Allgayer, H. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int. J. Cancer, 2012, 130(9), 2044-2053.
60. Vetter, G.; Saumet, A.; Moes, M.; Vallar, L.; Le Béchec, A.; Laurini, C.; Sabbah, M.; Arar, K.; Theillet, C.; Lecellier, C. H.; Friederich, E. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene 2010, 29(31), 4436-4448.
61. Moes, M.; Le Bechec, A.; Crespo, I.; Laurini, C.; Halavatyi, A.; Vetter, G.; Del Sol, A.; Friederich, E. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS One 2012, 7(4), e35440.
62. Liu, Y. N.; Yin, J. J.; Abou-Kheir, W.; Hynes, P. G.; Casey, O. M.; Fang, L.; Yi, M.; Stephens, R. M.; Seng, V.; Sheppard-Tillman, H.; Martin, P.; Kelly, K. MiR-1 and miR-200 inhibit EMT via Slugdependent and tumorigenesis via Slug-independent mechanisms. Oncogene 2013, 32(3), 296-306.
63. Li, B.; Han, Q.; Zhu, Y.; Yu, Y.; Wang, J.; Jiang, X. Downregulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist. FEBS J. 2012, 279(13), 2393-2398.
64. Ma, L.; Teruya-Feldstein, J.; Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449(7163), 682-688.
65. Ma, L.; Reinhardt, F.; Pan, E.; Soutschek, J.; Bhat, B.; Marcusson, E. G.; Teruya-Feldstein, J.; Bell, G. W.; Weinberg, R. A. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat. Biotechnol. 2010, 28(4), 341-347.
66. Perl, A. K.; Wilgenbus, P.; Dahl, U.; Semb, H.; Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998, 392(6672), 190-193.
67. Wijnhoven, B. P.; Dinjens, W. N.; Pignatelli, M. E-cadherincatenin cell-cell adhesion complex and human cancer. Br. J. Surg. 2000, 87(8), 992-1005.
68. Thiery, J. P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 2003, 15(6), 740-746.
69. Montserrat, N.; Gallardo, A.; Escuin, D.; Catasus, L.; Prat, J.; Gutiérrez-Avignó, F. J.; Peiró, G.; Barnadas, A.; Lerma, E. Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort? Hum. Pathol. 2011, 42(1), 103-110.
70. Ma, L.; Young, J.; Prabhala, H.; Ran, E.; Mestdaqh, P.; Muth, D.; Teruya-Feldstein, J.; Reinhardt, F.; Onder, T. T.; Valastyan, S.; Westermann, F.; Speleman, F.; Vandesompele, J.; Weinberg, R. A. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell. Biol. 2010, 12(3), 247-256.
71. Liu, Y.; Zhao, J.; Zhang, P. Y.; Zhang, Y.; Sun, S. Y.; Yu, S. Y.; Xi, Q. S. MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis. Med. Sci. Monit. 2012, 18(8), R299-R308.
72. Cao, M.; Seike, M.; Soeno, C.; Mizutani, H.; Kitamura, K.; Minegishi, Y.; Noro, R.; Yoshimura, A.; Cai, L.; Gemma, A. MiR-23a regulates TGF-beta-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. Int. J. Oncol. 2012, 41(3), 869-875.
73. Meng, Z.; Fu, X.; Chen, X.; Zeng, S.; Tian, Y.; Jove, R.; Xu, R.; Huang, W. miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 2010, 52(6), 2148-2157.
74. Acloque, H.; Adams, M. S.; Fishwick, K.; Bronner-Fraser, M.; Nieto, M. A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 2009, 119(6), 1438-1449.
75. Boyer, B.; Thiery, J. P. Epithelium-mesenchyme interconversion as example of epithelial plasticity. APMIS 1993, 101(4), 257-268.
76. Frankel, L. B.; Christoffersen, N. R.; Jacobsen, A.; Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 2008, 283(2), 1026-1033.
77. Asangani, I. A.; Rasheed, S. A.; Nikolova, D. A.; Leupold, J. H.; Colburn, N. H.; Post, S.; Allgayer, H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27(15), 2128-2136.
78. Subramanyam, D.; Lamouille, S.; Judson, R. L.; Liu, J. Y.; Bucay, N.; Derynck, R.; Blelloch, R. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol. 2011, 29(5), 443-448.
79. Wynn, T. A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214(2), 199-210.
80. Guarino, M.; Tosoni, A.; Nebuloni, M. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum. Pathol. 2009, 40(10), 1365-1376.
81. Lee, K.; Nelson, C. M. New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis. Int. Rev. Cell Mol. Biol. 2012, 294, 171-221.
82. Pandit, K. V.; Corcoran, D.; Yousef, H.; Yarlagadda, M.; Tzouvelekis, A.; Gibson, K. F.; Konishi, K.; Yousem, S. A.; Singh, M.; Handley, D.; Richards, T.; Selman, M.; Watkins, S. C.; Pardo, A.; Ben-Yehudah, A.; Bouros, D.; Eickelberg, O.; Ray, P.; Benos, P. V.; Kaminski, N. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2010, 182(2), 220-229.
83. Xia, H.; Hui, K. M. MicroRNAs involved in regulating epithelialmesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Cancer Gene Ther. 2012, 19(11), 723-730.
84. Brabletz, S.; Bajdak, K.; Meidhof, S.; Burk, U.; Niedermann, G.; Firat, E.; Wellner, U.; Dimmler, A.; Faller, G.; Schubert, J.; Brabletz, T. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 2011, 30(4), 770-782.
85. Hur, K.; Toiyama, Y.; Takahashi, M.; Balaguer, F.; Nagasaka, T.; Koike, J.; Hemmi, H.; Koi, M.; Boland, C.R.; Goel, A. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 2013, 62(9), 1315-1326.
86. Kong, D.; Li, Y.; Wang, Z.; Banerjee, S.; Ahmad, A.; Kim, H. R.; Sarkar, F. H. miR-200 regulates PDGF-D-mediated epithelialmesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 2009, 27(8), 1712-1721.
87. Howe, E. N.; Cochrane, D. R.; Richer, J. K. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res. 2011, 13(2), R45.
88. Davalos, V.; Moutinho, C.; Villanueva, A.; Boque R, Silva P, Carneiro F, Esteller M. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 2012, 31(16), 2062-2074.
89. Zhao, X.; Dou, W.; He, L.; Liang, S.; Tie, J.; Liu, C.; Li, T.; Lu, Y.; Mo, P.; Shi, Y.; Wu, K.; Nie, Y.; Fan, D. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulinlike growth factor-1 receptor. Oncogene 2013, 32(11), 1363-1372.
90. Decastro, A. J.; Dunphy, K. A.; Hutchinson, J.; Balbani, A. L.; Cherukuri, P.; Jerry, D. J.; DiRenzo, J. MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of DeltaNP63alpha and promotes mesenchymal-toepithelial transition. Cell Death Dis. 2013, 4, e514.
91. Xiong, M.; Jiang, L.; Zhou, Y.; Qiu, W.; Fang, L.; Tan, R.; Wen, P.; Yang, J. The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am. J. Physiol. Renal Physiol. 2012, 302(3), F369-F379.
92. Bronnum, H.; Andersen, D. C.; Schneider, M.; Sandberg, M. B.; Eskildsen, T.; Sheikh, S. P.; Nielsen, S. B.; Kalluri, R. miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty-1. PLoS One 2013, 8(2), e56280.
93. Bronnum, H.; Andersen, D. C.; Schneider, M.; Nossent, A. Y.; Nielsen, S. B.; Sheikh, S. P. Islet-1 is a dual regulator of fibrogenic epithelial-to-mesenchymal transition in epicardial mesothelial cells. Exp. Cell Res. 2013, 319(4), 424-435.
94. Faherty, N.; Curran, S. P.; O'Donovan, H.; Martin, F.; Godson, C.; Brazil, D. P.; Crean, J. K. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFbeta type II receptor with implications for nephropathic cell phenotypes. J. Cell Sci. 2012, 125(Pt 23), 5621-5629.
95. Du R.; Sun, W.; Xia, L.; Zhao, A.; Yu, Y.; Zhao, L.; Wang, H.; Huang, C.; Sun, S. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS One 2012, 7(2), e30771.
96. Tao, Z. H.; Wan, J. L.; Zeng, L. Y.; Xie, L.; Sun, H. C.; Qin, L. X.; Wang, L.; Zhou, J.; Ren, Z. G.; Li, Y. X.; Fan, J.; Wu, W. Z. miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma. J. Exp. Med. 2013, 210(4), 789-803.
97. Cai, J.; Guan, H.; Fang, L.; Yang, Y.; Zhu, X.; Yuan, J.; Wu, J.; Li, M. MicroRNA-374a activates Wnt/beta-catenin signaling to promote breast cancer metastasis. J. Clin. Invest. 2013, 123(2), 566-579.
98. Xu, Q.; Sun, Q.; Zhang, J.; Yu, J.; Chen, W.; Zhang, Z.L. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis 2013, 34(3), 539-549.
99. Lu, M. H.; Huang, C. C.; Pan, M. R.; Chen, H. H, Hung, W. C. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Clin. Cancer Res. 2012, 18(23), 6416-6425.